Company intelligence / Profile preview
BIOTON S.A.
- Ownership
- Private
- Employees
- ~364
- Development stage
- Commercial
Overview
BIOTON S.A. is a leading Polish biotechnology company specializing in the development, manufacturing, and commercialization of diabetes care solutions. It ranks among the world’s top eight commercial manufacturers of recombinant human insulin. Its portfolio includes finished insulin products, APIs for partners worldwide, oral diabetic drugs, injection devices like GensuPen2, and blood glucose monitoring technologies such as GensuCare glucometer. The company’s products are sold in over twenty countries across Europe, South America, Asia, and Africa[1][3].
- Therapeutic areas
- Endocrinology
- Modalities
- Recombinant proteinsSmall moleculesMedical devices
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on BIOTON S.A..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIOTON S.A..